Zeria Pharmaceutical Stock

JPY2,078.00

0.34% today

Tokyo, Jul 17, 08:15 am CET

ISIN

JP3428850006

Symbol

4559

Overview Dividends Analysts Charts Strategies

Zeria Pharmaceutical Stock price

JPY2,071.00

+169.00 8.89% 5Y

Tokyo, Closing price Wed, Jul 16 2025

+9.00 0.44%

ISIN

JP3428850006

Symbol

4559

Key metrics

Basic

Market capitalization

JPY93.0b

Enterprise Value

JPY110.6b

Net debt

JPY17.6b

Cash

JPY23.6b

Shares outstanding

44.1m

Valuation (TTM | estimate)

P/E

9.2 | 8.9

P/S

1.1 | 1.0

EV/Sales

1.3 | 1.2

EV/FCF

10.9

P/B

1.0

Dividends

DPS

JPY48.00

Yield 1Y | 5Y

2.3% | 2.0%

Growth 1Y | 5Y

2.1% | 7.1%

Payout 1Y | 3Y

20.9% | 24.2%

Increased

5 Years

Financials (TTM | estimate)

Revenue

JPY87.3b | JPY90.9b

EBITDA

JPY19.8b | JPY20.6b

EBIT

JPY12.2b | -

Net Income

JPY9.9b | JPY10.2b

Free Cash Flow

JPY10.2b

Growth (TTM | estimate)

Revenue

15.3% | 4.1%

EBITDA

105.3% | 4.3%

EBIT

33.4% | -

Net Income

28.5% | 2.7%

Free Cash Flow

23.0%

Financial Health

Equity Ratio

56.3%

Return on Equity

11.1%

ROCE

11.7%

ROIC

8.2%

Debt/Equity

0.5

EPS

JPY225.4

FCF per Share

JPY231.1

Short interest

Employees

Rev per Employee

JPY49.1m

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

Get Started for Free Today

Zeria Pharmaceutical Stock Analysis

Unlock Scores for Free

??

5 Analysts have issued a Zeria Pharmaceutical forecast:

4x Buy

80%

1x Hold

20%

More details on Analyst Estimates Including Price Targets

5 Analysts have issued a Zeria Pharmaceutical forecast:

Buy

80%

Hold

20%

Analyst Estimates with Stock Price Targets

Financial data from Zeria Pharmaceutical

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Mar '25		+/- %
Revenue	87,311 87,311	15% 15% 100%
- Direct Costs	23,351 23,351	15% 15% 27%
Gross Profit	63,960 63,960	15% 15% 73%
- Selling and Administrative Expenses	51,762 51,762	13% 13% 59%
- Research and Development Expense	- -	- -
EBITDA	19,752 19,752	105% 105% 23%
- Depreciation and Amortization	7,555 7,555	1,484% 1,484% 9%
EBIT (Operating Income) EBIT	12,198 12,198	33% 33% 14%
Net Profit	9,936 9,936	29% 29% 11%

In millions JPY.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Company Profile

Zeria Pharmaceutical Co., Ltd. engages in the manufacture, sale, import and export of pharmaceutical products. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 1,777 full-time employees. The firm operates in two business segments. The Ethical Drug segment is engaged in the research, development, manufacture and sale of ethical drugs. The Consumer Healthcare segment is engaged in the manufacture, purchase and sale of over-the-counter (OTC) drugs, health foods, quasi drugs and cosmetics related to self-medication. The others include insurance agency business and real estate business, as well as various maintenance business such as purchasing and sale of promotional materials.

Head office	Japan
Employees	1,777
Website	www.zeria.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now